...
首页> 外文期刊>Asian Journal of Transfusion Science >Detection of T and B cells specific complement-fixing alloantibodies using flow cytometry: A diagnostic approach for a resource limited laboratory
【24h】

Detection of T and B cells specific complement-fixing alloantibodies using flow cytometry: A diagnostic approach for a resource limited laboratory

机译:使用流式细胞仪检测T和B细胞特异性补体固定同种异体抗体:资源有限的实验室的一种诊断方法

获取原文
           

摘要

BACKGROUND AND OBJECTIVES: Various methods have been reported for the detection of antibodies in recipient sera, which can be human leukocyte antigens (HLAs) or non-HLA specific, complement- or noncomplement fixing, as well as donor T (HLA-Class-I) and/or B cell (HLA-Class-I and II) specific. These alloantibodies play a pivotal role in antibody-mediated renal transplantation rejection. Deposition of C4d in peritubular capillaries of a kidney biopsy is a marker of antibody-mediated rejection. The C4d flow-panel reactive antibodies (PRAs) are a screening method for HLA-specific and complement fixing antibodies. However, the method is limited by the lack of donor specificity. DESIGN AND SETTINGS: Here, we present a new and simple flow cytometric method referred to as C4d-flow cytometry crossmatch (C4d-FCXM) for the detection of donor-specific (T and/or B cell) and C4d-fixing alloantibodies. RESULTS: The method was applied in a series of clinical cases and judged to be useful. The method may limit unwanted deferral of the donor due to positivity in C4d Flow-PRA and/or FCXM and may be helpful in prediction of antibody mediated rejections. Furthermore, this method can provide information pretransplant in contrast to kidney biopsy and C4d evaluation done posttransplant. CONCLUSIONS: We postulate that this method incorporates most of the features of all the available modalities (i.e., National Institute of Health-complement dependent lymphocytotoxicity, FCXM, cytotoxic FCXM and C4d-flowPRA) yet cost-effective and best suited for resource-limited laboratory/ies which is a common scenario in developing countries.
机译:背景与目的:已经报道了多种检测受体血清中抗体的方法,这些方法可以是人白细胞抗原(HLA)或非HLA特异性,补体或非补体固定,以及供体T(HLA-I类)和/或B细胞(HLA-I和II类)特定。这些同种抗体在抗体介导的肾移植排斥中起关键作用。肾脏活检的肾小管毛细血管中C4d的沉积是抗体介导排斥的标志。 C4d流板反应性抗体(PRA)是HLA特异性和补体固定抗体的筛选方法。然而,该方法由于缺乏供体特异性而受到限制。设计和设置:在这里,我们提出了一种新的简单流式细胞术方法,称为C4d-流式细胞术交叉匹配(C4d-FCXM),用于检测供体特异性(T和/或B细胞)和固定C4d的同种抗体。结果:该方法已应用于一系列临床病例,并被认为是有用的。该方法可能会由于C4d Flow-PRA和/或FCXM中的阳性而限制供体的不必要延期,并且可能有助于预测抗体介导的排斥反应。此外,与肾脏活检和移植后进行的C4d评估相比,该方法可提供移植前的信息。结论:我们推测该方法具有所有可用模式的大多数功能(即美国国立卫生研究院补体依赖性淋巴细胞毒性,FCXM,细胞毒性FCXM和C4d-flowPRA),但具有成本效益,最适合资源有限的实验室/ ies,这在发展中国家很常见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号